Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02455791 · ClinicalTrials.gov registry record · NA

Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery

A NA study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT02455791: Active NA study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT02455791 is a NA study of Breast Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 43 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02455791, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to compare the use of an ultrasound-guided biopsy with what is found during surgery in finding evidence of the disease.

Conditions Studied

Interventions

  • PROCEDURE Ultrasound-Guided Biopsy

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2015-06-24
Est. Completion 2026-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02455791

The ClinicalTrials.gov registry entry for NCT02455791 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound-Guided Biopsy is the first listed.

NCT02455791 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02455791 about?

NCT02455791 is a clinical study titled "Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery". The goal of this clinical research study is to compare the use of an ultrasound-guided biopsy with what is found during surgery in finding evidence of the disease.

What is the current status of trial NCT02455791?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2015-06-24. Estimated completion is 2026-12-31.

What conditions does trial NCT02455791 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02455791?

The interventions under investigation include: Ultrasound-Guided Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02455791?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02455791 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.